Nathan Edwards

Nathan Edwards is the Head of Finance at Sonata Therapeutics. Nathan brings in almost 20 years of operational and financial experience, serving in leadership roles from early to commercial-stage companies. At Sonata, Nathan works with the management team to understand the financial impact of critical scientific and operational decisions.

Prior to Sonata, Nathan was a Senior Director of Finance at Flagship Pioneering, where he provided financial and operational oversight and was accountable for the continuous improvement, financial performance, and strategic capital investments of Flagship’s new companies. He was previously at Biogen, where he held multiple leadership roles in Finance and Strategy across Early-Stage Research and Development, Medical Affairs, Global Commercial and Corporate Functions. Nathan began his career as an auditor at Ernst and Young, overseeing a variety of sectors and industries.

Nathan received his B.S. in accounting from Fairfield University.